View in EDS PDF Full Text

Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy.

Saved in:
Bibliographic Details
Title: Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy.
Authors: Hsu SJ; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China., Chao YC; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China., Lin XH; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China., Liu HH; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Zhang Y; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China., Hong WF; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China., Chen MP; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Xu X; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Zhang L; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Ren ZG; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Du SS; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China., Chen RX; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Source: Clinical and experimental immunology [Clin Exp Immunol] 2023 Jun 05; Vol. 212 (3), pp. 239-248.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36966354
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hsu+SJ%22">Hsu SJ</searchLink>; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chao+YC%22">Chao YC</searchLink>; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Lin+XH%22">Lin XH</searchLink>; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Liu+HH%22">Liu HH</searchLink>; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Hong+WF%22">Hong WF</searchLink>; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chen+MP%22">Chen MP</searchLink>; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xu+X%22">Xu X</searchLink>; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Ren+ZG%22">Ren ZG</searchLink>; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Du+SS%22">Du SS</searchLink>; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chen+RX%22">Chen RX</searchLink>; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220057202%22">Clinical and experimental immunology</searchLink> [Clin Exp Immunol] 2023 Jun 05; Vol. 212 (3), pp. 239-248.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0057202 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099104%22">00099104 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36966354
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cei/uxad036
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 239
    Titles:
      – TitleFull: Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hsu SJ
      – PersonEntity:
          Name:
            NameFull: Chao YC
      – PersonEntity:
          Name:
            NameFull: Lin XH
      – PersonEntity:
          Name:
            NameFull: Liu HH
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Hong WF
      – PersonEntity:
          Name:
            NameFull: Chen MP
      – PersonEntity:
          Name:
            NameFull: Xu X
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Ren ZG
      – PersonEntity:
          Name:
            NameFull: Du SS
      – PersonEntity:
          Name:
            NameFull: Chen RX
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 06
              Text: 2023 Jun 05
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2249
          Numbering:
            – Type: volume
              Value: 212
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical and experimental immunology
              Type: main
ResultId 1